Blurbs

HEXO (HEXO) was Downgraded to a Hold Rating at Alliance Global Partners

HEXO (HEXOResearch Report) received a Hold rating and a $0.30 price target from Alliance Global Partners analyst Aaron Grey today. The company’s shares closed last Wednesday at $0.20.

According to TipRanks.com, Grey is a 2-star analyst with an average return of 1.0% and a 32.3% success rate. Grey covers the Basic Materials sector, focusing on stocks such as Green Thumb Industries, Trulieve Cannabis, and MediPharm Labs.

Currently, the analyst consensus on HEXO is a Hold with an average price target of $0.56.

See the top stocks recommended by analysts >>

The company has a one-year high of $6.24 and a one-year low of $0.22. Currently, HEXO has an average volume of 7.64M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Read More on HEXO:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos